Saturday 17 October 2026
Export RCEL’s income statement to Excel — free account
Avita Medical Inc.
RCEL Healthcare Medical Devices
Avita Medical Inc.’s revenue for fiscal 2025 (year ended December 2025) was $71.6 million, up 11.5% from fiscal 2024. In the quarter to June 2026, revenue grew 17.8%, EPS grew 33.8%, free cash flow grew 66.5% and total debt rose 10.5%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
13.04
0.37
−2.76%
Follow RCEL
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
3 | 3 | 3 | 4 |
+8 more TTM periods Free account |
| 211.55% | 326.92% | 799.72% | (1,746.27%) | ||
| (81.36%) | (74.88%) | (71.40%) | (67.07%) | ||
ROIC |
(306.20%) | (288.05%) | (334.18%) | (211.01%) | |
Return on Tangible Assets |
131.98% | 169.09% | 261.83% | 458.93% | |
Average Days of Receivables |
47.62 | 49.87 | 46.31 | 45.44 | |
Free Cash Flow per Share |
(16.42) | (21.22) | (23.57) | (26.15) | |
Free Cash Flow |
(25.25) | (32.40) | (32.83) | (37.13) | |
Capital Expenditures |
(1.02) | (1.44) | (1.64) | (3.29) | |
| Other line items | |||||
Cash ROIC |
(84.28%) | (87.01%) | (73.76%) | (62.83%) | |
Accounts Receivable Turnover |
7.13 | 6.60 | 6.86 | 7.46 | |
Accounts Payable Turnover |
2.04 | 1.70 | 1.68 | 1.91 | |
Inventory Turnover |
2.18 | 1.86 | 1.80 | 1.75 | |
Average Days of Payables |
168.06 | 195.44 | 255.59 | 251.43 | |
Days of Inventory on Hand |
138.33 | 165.58 | 197.59 | 224.54 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
26.64% | 27.90% | 29.10% | 27.62% | |
Selling, General and Administrative Expense of Revenue |
101.48% | 108.07% | 112.43% | 114.25% | |
Share Based Compensation of Revenue |
9.57% | 10.96% | 13.29% | 15.12% | |
Interest Coverage |
(6.97) | (7.73) | (8.71) | (6.78) | |
Operating CF/Net income |
0.56 | 0.68 | 0.64 | 0.70 | |
Depreciation/Fixed assets |
0.33 | 0.30 | 0.27 | 0.21 | |
Capex/Depreciation |
(0.41) | (0.59) | (0.70) | (1.60) | |
Revenue per Share |
49.19 | 47.38 | 51.41 | 51.00 | |
Operating CF per Share |
(15.76) | (20.27) | (22.39) | (23.83) | |
Capex per Share |
(0.66) | (0.94) | (1.18) | (2.32) | |
Capex to Sales |
0.01 | 0.02 | 0.02 | 0.05 |
Columns are period end dates